Prof. Dr. HACER DURMUŞ TEKÇE

Yayın Ağı

Makaleler 100

1. BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

Vu T., DURMUŞ TEKÇE H., Rivner M., Shroff S., Ragole T., Myers B., et al.

Nature Medicine , cilt.32, sa.3, ss.1131-1141, 2026 (SCI-Expanded, Scopus)

2. REM-related obstructive sleep apnoea in neuromuscular diseases: A 10-year retrospective cohort study

Oguz M. S., Kiyan E., Pihtili A., Altan G., Cakar A., Durmus H.

Sleep and Breathing , cilt.30, sa.1, 2026 (SCI-Expanded, Scopus)

3. BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Fedak R. R., Ruggerie R. N., Shan Y., Curvino E. J., de Sousa J. F., Daniel S., et al.

Nature Medicine , cilt.32, sa.3, ss.1118-1130, 2026 (SCI-Expanded, Scopus)

4. Subclinical Respiratory Muscle Weakness and Obstructive Sleep Apnea are Common in Glucosamine-UDP-N-acetyl-2-epimerase / N-acetylmannosamine kinase (GNE) Myopathy

KIYAN E., PIHTILI A., DURMUŞ TEKÇE H., Parman Y.

Annals of Indian Academy of Neurology , cilt.29, sa.1, ss.67-70, 2026 (SCI-Expanded, Scopus)

5. Kyphoscoliosis peptidase deficiency-induced myofibrillar degeneration, focal depletion of mitochondria, and protein aggregation: A true myofibrillar myopathy?

DURMUŞ TEKÇE H., Clemen C. S., ÖNAY UÇAR E., Hofmann A., Schlotzer-Schrehardt U., MERTOĞLU KAMALI E., et al.

JOURNAL OF NEUROMUSCULAR DISEASES , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Unraveling the Genetic Landscape of Hereditary Sensory and Autonomic Neuropathy in Turkiye

ÇAKAR A., Bagirova G., DURMUŞ TEKÇE H., UYGUNER Z. O., PARMAN F. Y.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.30, sa.3, ss.13, 2025 (SCI-Expanded, Scopus)

7. The Effect of Aerobic Exercise Training on Patients with Type III Spinal Muscular Atrophy

Mergen Kilic S., Mutluay F., Cakar A., Giris M., Durmus H., BİNGÜL İ., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.14, sa.17, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Genetic Heterogeneity of Distal Hereditary Motor Neuropathy in Turkiye: A Single Center Experience

ÇAKAR A., Candayan A., ERZURUMLUOĞLU GÖKALP E., DURMUŞ TEKÇE H., Houlden H., Battaloglu E., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.30, sa.3, ss.13, 2025 (SCI-Expanded, Scopus)

9. Sphingosine-1-Phosphate Phosphatase 1 Deficiency Leads to an Adult-Onset Hereditary Sensory Neuropathy with Mild Motor Involvement

ÇAKAR A., Bagirova G., GEDİKBAŞI A., KÜÇÜKGERGİN C., Giris M., DURMUŞ TEKÇE H., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.30, sa.3, ss.12-13, 2025 (SCI-Expanded, Scopus)

10. Early Electrodiagnostic Study in Guillain-Barré Syndrome Requires a Second One for Accurate Electrodiagnosis

Tasdemir V., Sirin N. G., Oge A. E., Cakar A., Culha A., Soysal A., et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY , cilt.42, sa.5, ss.470-471, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Eculizumab as a Rescue Therapy in Prolonged Myasthenic Crisis in the Intensive Care Unit: A Case Series

Durmus H., Çakar A., Gülşen Parman Y.

Neurocritical Care , cilt.42, sa.3, ss.1099-1101, 2025 (SCI-Expanded, Scopus)

12. Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension

Adams D., Wixner J., Polydefkis M., Berk J. L., Conceição I. M., Dispenzieri A., et al.

JAMA Neurology , cilt.82, sa.3, ss.228-236, 2025 (SCI-Expanded, Scopus)

13. Delineating the genetic landscape of Charcot-Marie-tooth disease in Türkiye: Distinct distribution, rare phenotypes, and novel variants

Cakar A., Candayan A., Bagırova G., UYGUNER Z. O., CEYLANER S., Durmus H., et al.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.32, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Current insights in ultra-rare adenylosuccinate synthetase 1 myopathy – meeting report on the First Clinical and Scientific Conference. 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, the United States of America

Rybalka E., Park H. J., Nalini A., Baskar D., Polavarapu K., Durmus H., et al.

Orphanet Journal of Rare Diseases , cilt.19, sa.1, 2024 (SCI-Expanded, Scopus)

15. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis

Altınönder İ., Kaya M., Yentür S. P., Çakar A., Durmuş H., Yegen G., et al.

Journal of Neuroinflammation , cilt.21, sa.1, 2024 (SCI-Expanded, Scopus)

16. Eculizumab Versus Rituximab for Refractory Antiacetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: A Single-Center Experience

DURMUŞ TEKÇE H., ÇAKAR A., Parman Y. G.

ACTA NEUROLOGICA SCANDINAVICA , cilt.2024, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. In vitro modulation of T cells in myasthenia gravis by low-dose IL-2

Çebi M., Çakar A., Durmuş H., Akan O., Aysal F., Parman Y., et al.

European Journal of Immunology , cilt.54, sa.11, 2024 (SCI-Expanded, Scopus)

18. Electrodiagnostic methods to verify Guillain-Barré syndrome subtypes in Istanbul: A prospective multicenter study

Tasdemir V., Sirin N. G., Cakar A., Culha A., Soysal A., Elmali A. D., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.29, sa.1, ss.72-81, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes

Ozdag Acarli A. N., Tuzun E., Sanli E., Koral G., Akbayir E., Cakar A., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.215, sa.1, ss.65-78, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Detection of gene variants associated with recessive limb–girdle muscular weakness and Pompe disease in a global cohort of patients through the application of next-generation sequencing analysis

Bevilacqua J. A., Al-Salti A. M., Al Madani A., Alves da Fonseca A., Durmus H., Chai J., et al.

Frontiers in Genetics , cilt.15, 2024 (SCI-Expanded, Scopus)

21. Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation

Karazi W., Scalco R. S., Stemmerik M. G., Løkken N., Lucia A., Santalla A., et al.

Orphanet Journal of Rare Diseases , cilt.18, sa.1, 2023 (SCI-Expanded, Scopus)

22. Phenotypic features of RETREG1-related hereditary sensory autonomic neuropathy

Çakar A., Bagırova G., Durmuş H., Uyguner O., Parman Y.

Journal of the Peripheral Nervous System , cilt.28, sa.3, ss.351-358, 2023 (SCI-Expanded, Scopus)

23. Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression

Cebi M., Cakar A., Erdogdu E., Durmus-Tekce H., Yegen G., Ozkan B., et al.

JOURNAL OF NEUROIMMUNOLOGY , 2023 (SCI-Expanded, Scopus)

24. A novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia

Çakar A., Pekbilir E., CEYLANER S., Durmuş H., Battaloğlu E., Şahin U., et al.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration , cilt.24, sa.5-6, ss.535-538, 2023 (SCI-Expanded, Scopus)

25. Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/myasthenia overlap syndrome and motor axonal polyneuropathy Pembrolizumab által kiváltott perifériás idegrendszeri károsodás: A myositis / myasthenia overlap szindróma és a motoros axonalis polyneuropathia kombinációja

Arman Ç., Ibrahim K., Elif O. K., Hacer D., Yeşim P.

Ideggyogyaszati Szemle , cilt.76, sa.11-12, ss.422-426, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective

ERDEM ÖZDAMAR S., KOÇ A. F., Durmus Tekce H., Kotan D., Ekmekci A. H., ŞENGÜN İ. Ş., et al.

Frontiers in Neurology , cilt.14, 2023 (SCI-Expanded, Scopus)

27. Disease activity in chronic inflammatory demyelinating polyneuropathy: A comparative study of clinical and skin biopsy markers

Acarli A. N. O., Unverengil G., Sirin N. G., Cakar A., Durmus H., Parman Y.

MUSCLE & NERVE , cilt.66, sa.6, ss.736-743, 2022 (SCI-Expanded, Scopus)

28. Desmin Knock-Out Cardiomyopathy: A Heart on the Verge of Metabolic Crisis

Elsnicova B., Hornikova D., Tibenska V., Kolar D., Tlapakova T., Schmid B., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.23, sa.19, 2022 (SCI-Expanded, Scopus)

29. Investigation of a Novel Recessive Mutation in Acetylcholine Receptor Epsilon-Subunit with Slow-Channel Kinetics Causing Congenital Myasthenia Reveals Subunit-Specific Contribution of Cys-Loop Length to Receptor Activation

Shen X., Shen S., Zhao Y., Di L., Durmus H., Deymeer F., et al.

ANNALS OF NEUROLOGY , cilt.92, 2022 (SCI-Expanded, Scopus)

30. Clinical and genetic characteristics of Emery-Dreifuss muscular dystrophy patients from Turkey: 30 years longitudinal follow-up study.

Yunisova G., CEYLANER S., Oflazer P., Deymeer F., Parman Y. G., Durmus H.

Neuromuscular disorders : NMD , cilt.32, sa.9, ss.718-727, 2022 (SCI-Expanded, Scopus)

31. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (canvas): an important cause of late-onset ataxia with unique clinical features

ÇAKAR A., Sahin E., Tezel S., Candayan A., Samanci B., BATTALOĞLU E., et al.

ACTA NEUROLOGICA BELGICA , cilt.122, sa.4, ss.939-945, 2022 (SCI-Expanded, Scopus)

32. AN EXPLORATORY STUDY OF COGNITIVE INVOLVEMENT IN HEREDITARY ATTRV

Durmus H., Cakar A., Demirci H., Parman Y.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.27, 2022 (SCI-Expanded)

33. Phenotypical spectrum of SACS variants: Neuromuscular perspective of a complex neurodegenerative disorder

Cakar A., Inci M., Acarli A. N. O., Comu S., Candayan A., BATTALOĞLU E., et al.

ACTA NEUROLOGICA SCANDINAVICA , cilt.145, ss.619-626, 2022 (SCI-Expanded, Scopus)

34. Lumbar Spinal Stenosis: A Rare Presentation of Hereditary Transthyretin Amyloidosis

Cakar A., Atmaca M. M., Kotan D., Durmus H., Deymeer F., Oflazer P., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.59, sa.1, ss.77-79, 2022 (SCI-Expanded, Scopus, TRDizin)

35. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine

Durmus H., Sticht H., Ceylaner S., Hashemolhosseini S., Deymeer F.

ACTA NEUROLOGICA BELGICA , cilt.121, sa.6, ss.1755-1760, 2021 (SCI-Expanded, Scopus)

36. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis

Durmus H., Cakar A., Demirci H., ALAYLIOĞLU M., GEZEN AK D., DURSUN E., et al.

ACTA NEUROLOGICA SCANDINAVICA , cilt.144, sa.6, ss.640-646, 2021 (SCI-Expanded, Scopus)

37. Genetic Survey of Autosomal Recessive Peripheral Neuropathy Cases Unravels High Genetic Heterogeneity in a Turkish Cohort

Candayan A., Çakar A., Yunisova G., Özdağ Acarlı A. N., Atkinson D., Topaloğlu P., et al.

NEUROLOGY-GENETICS , cilt.7, sa.5, 2021 (SCI-Expanded, Scopus)

38. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (Canvas) is an important cause of late-onset ataxia

Cakar A., Sahin E., Tezel S., Candayan A., Samanci B., BATTALOĞLU E., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.26, sa.3, ss.364, 2021 (SCI-Expanded, Scopus)

39. Episodic psychosis, ataxia, motor neuropathy with pyramidal signs (PAMP sydrome) caused by a novel mutation in ADPRHL2 (AHR3)

Durmus H., Mertoglu E., Sticht H., Ceylaner S., Kulaksizoglu I. B., Hashemolhosseini S., et al.

NEUROLOGICAL SCIENCES , cilt.42, sa.9, ss.3871-3878, 2021 (SCI-Expanded, Scopus)

40. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.

MOVEMENT DISORDERS , cilt.36, ss.1676-1688, 2021 (SCI-Expanded, Scopus)

41. Diaphragmatic dysfunction at the first visit to a chest diseases outpatient clinic in 500 patients with amyotrophic lateral sclerosis

Pihtili A., Bingol Z., Durmus H., Parman Y., Kiyan E.

MUSCLE & NERVE , cilt.63, ss.683-689, 2021 (SCI-Expanded, Scopus)

42. Late-onset TK2-Deficiency Patients from Turkey

DURMUŞ TEKÇE H., ÇAKAR A., PARMAN F. Y.

NEUROLOGY , sa.15, 2021 (SCI-Expanded, Scopus)

43. SOD1 Mutation: A Single Center Experience

ÇAKAR A., DURMUŞ TEKÇE H., PARMAN F. Y.

NEUROLOGY , sa.15, 2021 (SCI-Expanded, Scopus)

44. Genotypic and phenotypic features of mutations in the HINT1 gene among Turkish patients with hereditary axonal neuropathy

Acarli A. O., Cakar A., Candayan A., Durmus H., Ceylaner S., Matur Z., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.26, sa.1, ss.124-125, 2021 (SCI-Expanded, Scopus)

45. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)

Scalco R. S., Lucia A., Santalla A., Martinuzzi A., Vavla M., Reni G., et al.

ORPHANET JOURNAL OF RARE DISEASES , cilt.15, sa.1, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Cognition of the mothers of patients with Duchenne muscular dystrophy.

Demirci H., Durmus H., Toksoy G., Uslu A., Parman Y., Hanagasi H. A.

Muscle & nerve , cilt.62, sa.6, ss.710-716, 2020 (SCI-Expanded, Scopus)

47. The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

YILMAZ V., TÜZÜN E., DURMUŞ TEKÇE H., Oflazer P., Aysal F., Parman Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.349, 2020 (SCI-Expanded, Scopus)

48. Correlations between radiographic spinopelvic parameters and health-related quality of life: A prospective evaluation of 37 patients with facioscapulohumeral muscular dystrophy

Bayram S., Kendirci A. Ş., Karalar Ş., Durmuş Tekçe H., Parman F. Y., Akgül T., et al.

Clinical Neurology and Neurosurgery , cilt.198, 2020 (SCI-Expanded, Scopus)

49. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

Toepf A., Johnson K., Bates A., Phillips L., Chao K. R., England E. M., et al.

GENETICS IN MEDICINE , cilt.22, sa.9, ss.1478-1488, 2020 (SCI-Expanded, Scopus)

50. Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database

Tunca C., Seker T., Akcimen F., Coskun C., Bayraktar E., Palvadeau R., et al.

HUMAN MUTATION , cilt.41, sa.8, 2020 (SCI-Expanded, Scopus)

51. Four Individuals with a Homozygous Mutation in Exon 1f of thePLECGene and Associated Myasthenic Features

Mroczek M., DURMUŞ TEKÇE H., Topf A., Parman Y., Straub V.

GENES , cilt.11, sa.7, 2020 (SCI-Expanded, Scopus)

52. EVALUATION OF REPETITIVE NERVE STIMULATION WITH DIFFERENT STIMULATION FREQUENCIES IN PATIENTS WITH MYASTHENIA GRAVIS

Sirin N. G., KOCASOY ORHAN E., Oguz Akarsu E., DURMUŞ TEKÇE H., Deymeer F., BASLO M. B.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.83, sa.3, ss.197-203, 2020 (ESCI, TRDizin)

53. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS

Cebi M., DURMUŞ TEKÇE H., Aysal F., ÖZKAN B., Gul G. E., ÇAKAR A., et al.

Frontiers in Immunology , cilt.11, 2020 (SCI-Expanded, Scopus)

54. Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients

Mroczek M., DURMUŞ TEKÇE H., Bijarnia-Mahay S., Topf A., Ghaoui R., Bryen S., et al.

NEUROMUSCULAR DISORDERS , cilt.30, sa.4, ss.310-314, 2020 (SCI-Expanded, Scopus)

55. Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome

Yildiz Celik S., DURMUŞ TEKÇE H., YILMAZ V., SARUHAN DİRESKENELİ G., Gulsen Parman Y., Serdaroglu Oflazer P., et al.

ACTA NEUROLOGICA BELGICA , cilt.120, sa.1, ss.133-140, 2020 (SCI-Expanded, Scopus)

56. A Val30Met sporadic familial amyloid polyneuropathy case with atypical presentation: upper limb onset of symptoms

Sahin E., Cakar A., Durmus-Tekce H., Parman Y.

ACTA NEUROLOGICA BELGICA , cilt.119, sa.4, ss.627-628, 2019 (SCI-Expanded, Scopus)

57. A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID.

Akcimen F., Vural A., Durmus H., Cakar A., Houlden H., Parman Y. G., et al.

Journal of human genetics , cilt.64, sa.11, ss.1141-1144, 2019 (SCI-Expanded, Scopus)

58. The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype

Candayan A., Yunisova G., Cakar A., Durmus H., Basak A. N., Parman Y., et al.

NEUROGENETICS , 2019 (SCI-Expanded, Scopus)

59. Mutation spectrum of 260 dystrophinopathy patients from Turkey and important highlights for genetic counseling

Toksoy G., Durmus H., Aghayev A., Bagirova G., Rustemoglu B. S., Basaran S., et al.

NEUROMUSCULAR DISORDERS , sa.8, ss.601-613, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).

ÇEBI M., DURMUŞ H., YILMAZ V., YENTÜR S. P., AYSAL F., OFLAZER P., et al.

Clinical and experimental immunology , cilt.197, ss.214-221, 2019 (SCI-Expanded, Scopus)

61. Familial Amyloid Polyneuropathy

Cakar A., Durmus-Tekce H., Parman Y.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.56, sa.2, ss.150-156, 2019 (SCI-Expanded, Scopus, TRDizin)

62. Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population

Johnson K., De Ridder W., Topf A., Bertoli M., Phillips L., De Jonghe P., et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , cilt.90, sa.4, ss.490-493, 2019 (SCI-Expanded, Scopus)

63. Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis

Hocaoglu M., Durmus H., Ozkan B., Yentur S. P., Dogan O., Parman Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.323, ss.36-42, 2018 (SCI-Expanded, Scopus)

64. Repetitive nerve stimulation and jitter measurement with disposable concentric needle electrode in newly diagnosed myasthenia gravis patients

Sirin N. G., Orhan E., Durmus H., Deymeer F., Baslo M. B.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY , cilt.48, sa.5, ss.261-267, 2018 (SCI-Expanded, Scopus)

65. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness

Johnson K., Bertoli M., Phillips L., Topf A., Van den Bergh P., Vissing J., et al.

SKELETAL MUSCLE , cilt.8, 2018 (SCI-Expanded, Scopus)

66. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up

Durmus H., SHEN X., Serdaroglu-Oflazer P., Kara B., Parman-Gulsen Y., Ozdemir C., et al.

NEUROMUSCULAR DISORDERS , cilt.28, sa.4, ss.315-322, 2018 (SCI-Expanded, Scopus)

67. A database for screening and registering late onset Pompe disease in Turkey

GOKYIGIT M. C., Ekmekci H., Durmus H., Karll N., Koseoglu E., AYSAL F., et al.

NEUROMUSCULAR DISORDERS , cilt.28, sa.3, ss.262-267, 2018 (SCI-Expanded, Scopus)

68. Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor epsilon-subunit

SHEN X., BRENGMAN J. M., SHEN S., Durmus H., PREETHISH-KUMAR V., Yuceyar N., et al.

JCI INSIGHT , cilt.3, sa.2, 2018 (SCI-Expanded, Scopus)

69. Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease

Inal-Gultekin G., Toptas-Hekimoglu B., Gormez Z., Gelisin O., Durmus H., ERGUNER B., et al.

NEUROMUSCULAR DISORDERS , cilt.27, sa.11, ss.997-1008, 2017 (SCI-Expanded, Scopus)

70. Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

Giris M., Durmus H., Yetimler B., Tasli H., Parman Y., Tuzun E.

IN VIVO , sa.4, ss.657-660, 2017 (SCI-Expanded, Scopus)

71. MUSCLE MAGNETIC RESONANCE IMAGING IN SPINAL MUSCULAR ATROPHY TYPE 3: SELECTIVE AND PROGRESSIVE INVOLVEMENT

Durmus H., Yilmaz R. S., Gulsen-Parman Y., Oflazer-Serdaroglu P., CUTTINI M., Dursun M., et al.

MUSCLE & NERVE , cilt.55, sa.5, ss.651-656, 2017 (SCI-Expanded, Scopus)

72. Jitter measurement using a concentric needle in 133 patients with myasthenia gravis: A retrospective analysis

Sirin N. G., Orhan E. K., Durmus H., Oflazer P., Parman Y., Oge A. E., et al.

Journal of Neurological Sciences , cilt.34, sa.3, ss.207-214, 2017 (SCI-Expanded, Scopus, TRDizin)

73. Neuromuscular endplate pathology in recessive desminopathies: Lessons from man and mice

Durmus H., Ayhan O., CIRAK S., Deymeer F., Parman Y., FRANKE A., et al.

NEUROLOGY , sa.8, ss.799-805, 2016 (SCI-Expanded, Scopus)

74. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.

Durmus-Tekce H., MATUR Z., Atmaca M. M., Poda M., Cakar A., ULAS U. H., et al.

Neuromuscular disorders : NMD , cilt.26, sa.7, ss.441-6, 2016 (SCI-Expanded, Scopus)

75. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.

Saruhan-Direskeneli G., HUGHES T., Yilmaz V., Durmus H., ADLER A., Alahgholi-Hajibehzad M., et al.

Clinical immunology (Orlando, Fla.) , ss.81-8, 2016 (SCI-Expanded, Scopus)

76. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

Stergiou C., Lazaridis K., Zouvelou V., Tzartos J., Mantegazza R., Antozzi C., et al.

Journal of neuroimmunology , cilt.292, ss.108-15, 2016 (SCI-Expanded, Scopus)

77. Myasthenia gravis after botulinum toxin type A injection Botulinum toksin tip A enjeksiyonu sonrası açığa çıkan myasthenia gravis olgusu

Tekce H., Deymeer F., Serdaroglu P. O., Parman Y.

Turk Noroloji Dergisi , cilt.22, sa.3, ss.143-144, 2016 (Scopus, TRDizin)

78. Vocal Cord Paralysis and Hypercapnic Respiratory Failure in a Patient with Familial Amyloidotic Polyneuropathy

PIHTILI A., Bingol Z., Durmus H., Parman Y., Kiyan E.

INTERNAL MEDICINE , sa.13, ss.1783-1786, 2016 (SCI-Expanded, Scopus)

79. Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice.

Ozkok E., Durmus H., Yetimler B., Tasli H., TRAKAS N., Ulusoy C. A., et al.

Clinical neuropathology , cilt.34, sa.6, ss.359-63, 2015 (SCI-Expanded, Scopus)

80. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.

Tsonis A. I., Zisimopoulou P., Lazaridis K., Tzartos J., Matsigkou E., Zouvelou V., et al.

Journal of neuroimmunology , cilt.284, ss.10-7, 2015 (SCI-Expanded, Scopus)

81. Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK

Yilmaz V., Oflazer P., AYSAL F., Durmus H., Poulas K., Yentur S. P., et al.

PLoS ONE , cilt.10, sa.4, 2015 (SCI-Expanded, Scopus)

82. Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.

Alahgholi-Hajibehzad M., Oflazer P., Aysal F., Durmus H., Gulsen-Parman Y., MARX A., et al.

Journal of neuroimmunology , cilt.281, ss.51-60, 2015 (SCI-Expanded, Scopus)

83. The distinct genetic pattern of ALS in Turkey and novel mutations

Ozoguz A., Uyan O., Birdal G., Iskender C., Kartal E., Lahut S., et al.

Neurobiology of Aging , cilt.36, sa.4, 2015 (SCI-Expanded, Scopus)

84. Prevalence of Parkinson's disease in Baskale, Turkey: a population based study

Durmus H., Gökalp M. A., Hanagasi H. A.

NEUROLOGICAL SCIENCES , cilt.36, sa.3, ss.411-413, 2015 (SCI-Expanded, Scopus)

85. Association between restless leg syndrom and slow coronary flow

ERDEN I., ERDEN E. C., Durmus H., Tibilli H., TABAKCI M., KALKAN M. E., et al.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.14, sa.7, ss.612-616, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

86. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

ZISIMOPOULOU P., EVANGELAKOU P., TZARTOS J., LAZARIDIS K., ZOUVELOU V., MANTEGAZZA R., et al.

Journal of Autoimmunity , cilt.52, ss.139-145, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Facial and Skeletal Muscle Magnetic Resonance Imaging in Oculopharyngodistal Myopathy

DURMUŞ TEKÇE H., Dursun M., Sencer S., Deymeer F., Oflazer-Serdaroglu P.

TURKISH JOURNAL OF NEUROLOGY , cilt.20, sa.4, ss.121-125, 2014 (ESCI, Scopus)

88. Prevalence of Parkinson's disease in Baskale, Turkey: A population-based study

Durmus H., Gokalp M. A., Hanagasi H. A.

MOVEMENT DISORDERS , cilt.28, 2013 (SCI-Expanded, Scopus)

89. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures

Durmus H., Kurtuncu M., Tuzun E., Pehlivan M., Akman-Demir G., Yapici Z., et al.

Acta Neurologica Belgica , cilt.113, sa.4, ss.421-426, 2013 (SCI-Expanded, Scopus)

90. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis

Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.

NEUROLOGY INDIA , cilt.59, sa.1, ss.47-50, 2011 (SCI-Expanded, Scopus)

91. SLEEP RELATED BREATHING DISORDERS AND LUNG FUNCTION IN PATIENTS WITH OCULOPHARYNGODISTAL MYOPATHY

Memis U., Kiyan E., Durmus H., Oflazer P.

RESPIROLOGY , cilt.15, ss.106, 2010 (SCI-Expanded, Scopus)

92. Unihemispheric acute disseminated encephalomyelitis: A case report Tek hemisferi tutan akut dissemine ensefalomiyelit: Olgu sunumu

Durmus H., TURKOGLU R., Tuzun E.

Noropsikiyatri Arsivi , cilt.47, sa.2, ss.166-168, 2010 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

93. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations

Schara U., Christen H., Durmus H., Hietala M., Krabetz K., Rodolico C., et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , cilt.14, sa.4, ss.326-333, 2010 (SCI-Expanded, Scopus)

94. Amphiphysin Autoimmunity: Associated Neurological Syndromes and Tumors in The Turkish Population

Tuzun E., Bebek N., Icoz S., Durmus H., Kurtuncu M., Gurses C., et al.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.27, sa.2, ss.121-126, 2010 (SCI-Expanded, TRDizin)

95. Sensorimotor neuropathy associated with endometrioid endometrial carcinoma

Durmus H., Tuzun E., Icoz S., Akman-Demir G., Parman Y.

European Journal of Obstetrics and Gynecology and Reproductive Biology , cilt.150, sa.2, ss.216-217, 2010 (SCI-Expanded, Scopus)

96. Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients

Icoz S., Tuzun E., Kurtuncu M., Durmus H., Mutlu M., Eraksoy M., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.1, ss.71-75, 2010 (SCI-Expanded, Scopus)

97. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids

Kurtuncu M., Tuzun E., Durmus H., Mutlu M., Akman-Demir G., Eraksoy M.

Leukemia and Lymphoma , cilt.50, sa.9, ss.1552-1553, 2009 (SCI-Expanded, Scopus)

98. Antinuclear antibodies in juvenile myoclonic epilepsy

Altindag E., Icoz S., Tuzun E., Durmus H., Uludokumaci A., Demir G. A., et al.

Journal of Neurological Sciences , cilt.26, sa.1, ss.43-48, 2009 (Scopus, TRDizin)

99. Pregnancy-Induced Atypic Demyelinating Inflammatory Disease

Durmus H., Tuzun E., Kurtuncu M., Mutlu M., Demir G. A., Eraksoy M.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.2, ss.80-83, 2009 (SCI-Expanded, Scopus, TRDizin)

100. Development of Multiple Sclerosis in Patients with Optic Neuritis: Analysis of Predictive Factors

Durmuş Tekçe H., Kürtüncü M., Tüzün E., Akalın B., Mutlu M., Akman-Demir G., et al.

Turkish Journal of Neurology , cilt.15, sa.3, ss.119-123, 2009 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 76

1. MME ilişkili Charcot-Marie-Tooth Hastalığı’nda Merkezi Sinir Sistemi Tutulumu Olgusu: Neden mi, Rastlantı mı?

Ateş D., Çakar A., Durmuş Tekçe H., Parman F. Y.

8. Nöromüsküler Hastalıklar Kongresi, Nevşehir, Türkiye, 2 - 05 Kasım 2025, ss.33, (Özet Bildiri)

2. Re-purposing Primidone as a RIPK1 inhibitor in OPTN-and TBK1-related ALS: a case series

DURMUŞ TEKÇE H., Gezen-AK D., DURSUN E., ÇAKAR A., KIYAN E., Parman Y. G.

30th Annual Congress of the World-Muscle-Society (WMS), Vienna, Avusturya, 7 - 11 Ekim 2025, cilt.53, (Özet Bildiri)

3. Eculizumab as a rescue therapy in myasthenic crisis in ICU: a case series

DURMUŞ TEKÇE H., ÇAKAR A., Parman Y. G.

30th Annual Congress of the World-Muscle-Society (WMS), Vienna, Avusturya, 7 - 11 Ekim 2025, cilt.53, (Özet Bildiri)

4. Clinical and Molecular Landscape of Amyotrophic Lateral Sclerosis Patients with OPTN Variants from Turkey and Possible Therapeutic Response to Inhibation of RIPK1

DURMUŞ TEKÇE H., ERZURUMLUOĞLU GÖKALP E., Gezenak D., Dursun E., Alaylioglu M., ÇAKAR A., et al.

Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2025, cilt.104, (Özet Bildiri)

5. Riboflavin Responsive Slowly Progressive Early Onset Motor Neuron Disease Caused by a Novel Mutation in AIFM1

DURMUŞ TEKÇE H., ERZURUMLUOĞLU GÖKALP E., Ucar E. O., ÇAKAR A., Ceylaner S., Uyguner O., et al.

Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2025, cilt.104, (Özet Bildiri)

6. GENETIC LANDSCAPE OF CHARCOT-MARIE-TOOTH DISEASE IN TURKIYE: DISTINCT DISTRIBUTION, RARE PHENOTYPES, AND NOVEL VARIANTS

Çakar A., Candayan A., Bagirova G., Uyguner Z. O., Ceylaner S., Durmuş Tekçe H., et al.

Annual Meeting of the Peripheral-Nerve-Society (PNS), Montreal, Kanada, 22 - 25 Haziran 2024, cilt.29, ss.11, (Özet Bildiri)

7. Long-term follow-up of five families from Turkey with UBQLN2 variants

Durmus H., ÇAKAR A., Aysal F., Ertas M., Basak N., Parman Y.

21st Annual Meeting of the Northeast-Amyotrophic-Lateral-Sclerosis-Consortium (NEALS), Florida, Amerika Birleşik Devletleri, 1 - 03 Kasım 2022, (Özet Bildiri)

8. Correlations Between Radiographic Spinopelvic Parameters And Health-Related Quality Of Life: A Prospective Evaluation Of 37 Patients With Facioscapulohumeral Muscular Dystrophy

BAYRAM S., KENDİRCİ A. Ş., KARALAR Ş., DURMUŞ TEKÇE H., PARMAN F. Y., AKGÜL T., et al.

23nd EFORT Congress, Lisbon, Portekiz, 22 - 24 Haziran 2022, cilt.23, (Tam Metin Bildiri)

9. GNE miyopatisinde solunumsal problemler

Dikmen B., Pıhtılı A., Kıyan E., Parman F. Y., Durmuş Tekçe H.

Türk Toraks Derneği 25. Yıllık Kongresi, Antalya, Türkiye, 24 - 28 Mayıs 2022, ss.896, (Özet Bildiri)

10. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis

Durmus H., ÇAKAR A., Demirci H., Parman F. Y.

Annual Meeting of the American-Academy-of-Neurology, Washington, Amerika Birleşik Devletleri, 2 - 07 Nisan 2022, (Özet Bildiri)

11. Pandemi Öncesi ve Pandemi Döneminde Guillain-Barré Sendromunun Klinik ve Elektrofizyolojik Özellikleri: Çok Merkezli İstanbul Çalışması

Taşdemir V., Şirin İnan N. G., Çakar A., Çulha A., Soysal A., Elmalı Yazıcı A. D., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Yayınlanmadı)

12. YAYGIN HİPERPİGMENTASYON İLE BAŞVURAN BİR DERMATOMİYOZİT OLGUSU

GEZEGEN H., ALTINKAYNAK M., ÇAKAR A., DURMUŞ TEKÇE H., AKPINAR T. S., PARMAN F. Y.

57. Ulusal nöroloji kongresi, Antalya, Türkiye, 27 Kasım 2021, (Özet Bildiri)

13. Effects of immunosuppressive treatment on thymocyte maturation in Myasthenia Gravis patiens

Yentür S. P., Durmuş Tekçe H., Erdoğdu E., Yegen G., Yılmaz V., Özkan B., et al.

European Congress of Immunology, Belgrade, Sırbistan, 1 - 04 Eylül 2021, ss.78, (Özet Bildiri)

14. Expanding the phenotypical spectrum of SACS mutation: A Single Center Experience

ÇAKAR A., İNCİ M., ÖZDAĞ ACARLI A. N., DURMUŞ TEKÇE H., PARMAN F. Y.

Virtual Annual Meeting of the American-Academy-of-Neurology, ELECTR NETWORK, 17 - 22 Nisan 2021, (Özet Bildiri)

15. Cognitive involvement in transthyretin-related familial amyloid polyneuropathy (TTR-FAP)

DURMUŞ TEKÇE H., ÇAKAR A., Demirci H., PARMAN F. Y.

Virtual Annual Meeting of the American-Academy-of-Neurology, ELECTR NETWORK, 17 - 22 Nisan 2021, (Özet Bildiri)

16. Episodic psychosis, ataxia, motor neuropathy caused by a novel mutation in ADPRHL2

DURMUŞ TEKÇE H., Hashemolhosseini S., CEYLANER S., PARMAN F. Y.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 Ocak 2020, ss.558, (Özet Bildiri)

17. Cognitive involvement in ATTR amyloidosis (TTR-FAP)

DURMUŞ TEKÇE H., ÇAKAR A., Demirci H., Alaylioglu M., GEZEN AK D., DURSUN E., et al.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 Ocak 2020, ss.527, (Özet Bildiri)

18. Clinical features of a homozygous missense mutation in the FXN gene resulting in a Charcot-Marie-Tooth-like phenotype

ÇAKAR A., Candayan A., Yunisova G., Battaloglu E., DURMUŞ TEKÇE H., PARMAN F. Y.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 Ocak 2020, ss.490, (Özet Bildiri)

19. Amiyotrofik Lateral Skleroz Olgularında Solunumsal Problemler Ve Sağkalım

THURA M., PIHTILI A., DURMUŞ TEKÇE H., PARMAN F. Y., BİNGÖL Z., KIYAN E.

TÜRK TORAKS DERNEĞİ 23. YILLIK KONGRESİ, Türkiye, 15 - 18 Ekim 2020, (Özet Bildiri)

20. 3 individuals with mutation in exon 1f of PLEC and myasthenic phenotype

Mroczek M., Durmus H., Topf A., Duff J., Parman Y., Straub V.

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 Mayıs 2020, cilt.27, ss.1151, (Özet Bildiri)

21. Clinical And Genetic Characteristics of Bethlem Myopathy Patients from Turkey

Yunisova G., Ceylaner S., Deymeer F., Oflazer P., Durmus H., Parman Y.

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 Mayıs 2020, cilt.27, ss.1158, (Özet Bildiri)

22. Circulating B Cell Subsets and Cytokine Gene Expression Levels in Peripheral Blood and Skin Biopsy in Chronic Inflammatory Demyelinating Polyneuropathy

Acarli A. N. O., Yilmaz V., Sirin N. G., ÇAKAR A., Soysal A., Aysal F., et al.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, (Özet Bildiri)

23. Skin Biopsy as a Biomarker in Chronic Inflammatory Demyelinating Polyneuropathy

Parman Y., Acarli A. N. O., ÜNVERENGİL G., Sirin N. G., ÇAKAR A., DURMUŞ TEKÇE H.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, (Özet Bildiri)

24. EPISODIC PSYCHOSIS, ATAXIA, MOTOR NEUROPATHY CAUSED BY A NOVEL MUTATION IN ADPRHL2

DURMUŞ TEKÇE H., Sticht H., Ceylaner S., Hashemolhosseini S., Parmn Y.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri)

25. Studying Clinical and Genetic Characteristics of Emery-Dreifuss Muscular Dystrophy

Yunisova G., Oflazer P., Deymeer F., ÇAKAR A., PARMAN F. Y., DURMUŞ TEKÇE H.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri)

26. Clinical and genetic features of SPG11: A Single Center Experience

Cakar A., Gezegen H., Tunca C., Bayraktar E., Basak N., Durmus-Tekce H., et al.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri)

27. Antibodies Against Peripheral Nerve Antigens in Chronic Inflammatory Demyelinating Polyradiculoneuropathy in a Turkish Cohort

ÖZDAĞ ACARLI A. N., VURAL A., YILMAZ V., Şirin N., DURMUŞ TEKÇE H., SARUHAN DİRESKENELİ G., et al.

2019 PNS (Peripheral Nerve Society) Annual Meeting, Cenova, İtalya, 21 - 26 Haziran 2019

28. Autosomal Recessive Charcot-Marie-Tooth Disease in Turkey

Parman Y., Cakar A., Candayan A., Akcay H. I., Yunisova G., Ulukan Ç., et al.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

29. GNE MYOPATHY in TURKEY: CLINICAL FEATURES AND NOVEL MUTATIONS

Durmus H., Ceylaner S., Parman F. Y., Deymeer F., Serdaroglu P.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

30. Congenital myasthenic syndromes due to impaired principal coupling pathway in the epsilon-subunit of muscle acetylcholine receptor

Shen X., Selcen D., Brengman J., Shen S., Durmus H., Preethish-Kumar V., et al.

23rd International Annual Congress of the World-Muscle-Society (WMS), Mendoza, Arjantin, 2 - 06 Ekim 2018, cilt.28, (Özet Bildiri)

31. Congenital Myasthenic Syndromes (CMS) Due to Impaired Principal Coupling Pathway in the. Subunit of Muscle Acetylcholine Receptor (AChR)

Shen X., Brengman J., Shen S., Durmus H., Preethish-Kumar V., Yuceyar N., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

32. Clinical and Genetic Features in X-Linked Charcot-Marie-Tooth Neuropathy (CMT-X) Patients from Turkey

Parman Y., Durmus H., Candayan A., Akcay H. I., Yunisova G., Ulukan Ç., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

33. Klinik Fasilitasyonun Eşlik Ettiği Myasthenia Gravis: Olgu Serisi

ATMACA M. M., DURMUŞ TEKÇE H., KOCASOY ORHAN E., BASLO M. B., DEYMEER F.

34.Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Türkiye, 4 - 08 Nisan 2018

34. GENOTYPIC AND PHENOTYPIC PRESENTATION OF TRANSTHYRETIN- RELATED FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP) IN TURKEY

Durmus H., Cakar A., Sahin E., Matur Z., Poda M., Altunoglu U., et al.

Peripheral-Nerve-Society Meeting, Sitges, İspanya, 8 - 12 Temmuz 2017, cilt.22, ss.276-277, (Özet Bildiri)

35. Congenital myasthenic syndromes in Turkey

Durmus H., Kara B., Parman Y., Oflazer P., Deymeer F.

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Hollanda, 01 Haziran 2017, cilt.24, ss.500, (Özet Bildiri)

36. PAROKSİSMAL DİZARTRİ VE ATAKSİ ATAKLARIYLA BAŞVURAN LEPTOMENİNGEAL TUTULUMLA GİDEN MEME KANSERİ OLGUSU

Uygun Ö., Sezgin M., Durmuş Tekçe H., Baykan B.

52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016, ss.97-98, (Özet Bildiri)

37. CHARCOT-MARIE-TOOTH DISEASE IN TURKEY: CLINICAL AND GENETIC FINDINGS FROM A SINGLE-CENTRE EXPERIENCE

Akcay H., Durmus H., Deymeer F., Oflazer-Serdaroglu P., Sivaci M., Candayan A., et al.

Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and Ceilidh, Glasgow, Birleşik Krallık, 21 - 24 Haziran 2016, cilt.21, ss.230-231, (Özet Bildiri)

38. Clinical and Genetic Heterogeneity in Charcot-Marie-Tooth Neuropathy Type 2 Patients from Turkey

Durmus H., Akcay H. I., Sivaci M., Serdaroglu P., Deymeer F., Battaloglu E., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)

39. Clinical and Genetic Heterogeneity in Familial ALS Patients from Turkey

Durmus H., Sezgin M., Samanci B., Ozoguz A., Deymeer F., Serdaroglu P., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, (Özet Bildiri)

40. TÜRK TOPLUMUNDA EN SIK RASTLANILAN MİYOFOSFORİLAZ (PYGM) MUTASYONLARI: MCARDLE HASTALIĞININ GENETİK TANISI İÇİN YENİ NESİL DİZİLEME

İNAL GÜLTEKİN G., TOPTAŞ HEKİMOĞLU B., GÖRMEZ Z., DURMUŞ TEKÇE H., SAĞIROĞLU M. Ş., DEMİRCİ H., et al.

51. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 03 Aralık 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

41. Genotypic and phenotypic presentation of Glu89Gln mutation in Turkey

DURMUŞ TEKÇE H., MATUR Z., ATMACA M. M., PODA M., ÇAKAR A., SERDAROĞLU OFLAZER P., et al.

First European Congress on Hereditary ATTR amyloidosis, Fransa, 2 - 03 Kasım 2015

42. Evaluation of maximum oxygen utilization in McArdle patients before and after exercise training

Gelisin O., Durmus H., Yakal S., Kasikcioglu E., Parman Y., Deymeer F., et al.

20th International Congress of the World-Muscle-Society, Brighton, Birleşik Krallık, 30 Eylül - 04 Ekim 2015, cilt.25, (Özet Bildiri)

43. **Myophosphorylase (PYGM) mutations in Turkish patients with McArdle disease: A next generation sequencing study**

Gultekin G. I., Hekimoglu B. T., Gormez Z., Durmus H., Demirci H., Sagiroglu M., et al.

20th International Congress of the World-Muscle-Society, Brighton, İngiltere, 30 Eylül - 04 Ekim 2015, (Özet Bildiri)

44. GENETIC SURVEY OF A LARGE COHORT OF CMT PATIENTS FROM TURKEY REVEALED EQUAL FREQUENCIES OF CMT1A DUPLICATION AND HNPP DELETION

Ozes B., Sivaci M., Akyuz K., Durmus H., Deymeer F., Oflazoglu P., et al.

Biennial Meeting of the Peripheral-Nerve-Society, Quebec, Kanada, 27 Haziran - 02 Temmuz 2015, cilt.20, ss.205, (Özet Bildiri)

45. Ocular myasthenia gravis

Uyar T., Durmus H., Parman Y., Serdaroglu-Oflazer P., Saruhan-Direskeneli G., Deymeer F.

1st Congress of the European-Academy-of-Neurology, Berlin, Almanya, 20 - 23 Haziran 2015, cilt.22, ss.720, (Özet Bildiri)

46. **CLINICAL AND GENETIC CHARACTERISTICS OF 20 ALS PATIENTS FROM TURKEY WITH SOD1 MUTATIONS**

Samanci B., Durmus H., Ozoguz A., Oflazer-Serdaroglu P., Deymeer F., Basak A. N., et al.

Biennial Meeting of the Peripheral-Nerve-Society, Quebec, Kanada, 27 Haziran - 02 Temmuz 2015, ss.224-225, (Özet Bildiri)

47. Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice

Durmus H., Ozkok E., Yetimler B., Tuzun E.

1st Congress of the European-Academy-of-Neurology, Berlin, Almanya, 20 - 23 Haziran 2015, cilt.22, ss.720

48. Myasthenia gravis hastalarının elektrofizyolojik incelemelerine retrospektif bir bakış

ŞİRİN N. G., KOCASOY ORHAN E., DURMUŞ TEKÇE H., BASLO M. B., DEYMEER F.

31. ulusal klinik nörofizyoloji EEG-EMG kongresi, Türkiye, 8 - 12 Nisan 2015

49. İ.T.F. NÖROLOJİ ANABİLİM DALINDA İZLENEN AMYOTROFİK LATERAL SKLEROZ HASTALARININ GENETİK VE KLİNİK ÖZELLİKLER AÇISINDAN İNCELENMESİ

Sezgin M., Samancı B., Durmuş Tekçe H., Özoğuz A., Oflazer Serdaoğlu P., Deymeer F., et al.

50. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 22 Kasım - 26 Aralık 2014, ss.90-91, (Özet Bildiri)

50. Differential cytokine changes in myasthenia gravis patients with antibodies against AChR and Musk

Yilmaz V., Oflazer P., Aysal F., Durmus H., Poulos K., Parman Y., et al.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.212-213, (Özet Bildiri)

51. Dramatic improvement after injection augmentation in oculopharyngodistal myopathy

Ozcan O., Durmus H., Tarhan O., Polat Z., Deymeer F., Parman Y., et al.

19th International Congress of the World-Muscle-Society, Berlin, Almanya, 7 - 11 Ekim 2014, cilt.24, ss.796, (Özet Bildiri)

52. Late-onset non-thymomatous generalized myasthenia gravis

Yildiz-Celik S., Durmus H., Hajibehzad M., Yilmaz V., Oflazer-Serdaroglu P., Parman Y., et al.

19th International Congress of the World-Muscle-Society, Berlin, Almanya, 7 - 11 Ekim 2014, cilt.24, ss.842, (Özet Bildiri)

53. Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation

Matur Z., Atmaca M. M., Durmus H., Parman Y.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.21, ss.543, (Özet Bildiri)

54. Whole exome sequencing analysis in recessive hereditary spastic paraplegia patients from Turkey

Ozes B., Gonzalez M., Durmus H., Deymeer F., Oflazoglu P., Zuechner S., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

55. Genotypic and phenotypic presentation of TTR-FAP in Turkey

Durmus H., Matur Z., Atmaca M. M., PODA M., Oflazer-Serdaroglu P., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

56. Genotypic and phenotypic presentation of TTR-FAP in Turkey

Durmus H., Matur Z., Atmaca M. M., Poda M., Oflazer-Serdaroglu P., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.21, ss.137, (Özet Bildiri)

57. Exome sequencing vs phenotype directed gene screening in CMT patients from Turkey

Sivaci M., Parman Y., Gonzaga-Jauregui C., Pehlivan D., Durmus H., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

58. Clinical and genetic features of patients with MNGIE: cohort at the department of neurology, Istanbul Faculty of Medicine

Cakar A., Durmus H., Gunduz T., Deymeer F., Parman Y., Oflazer-Serdaroglu P.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.21, ss.519, (Özet Bildiri)

59. Exome sequencing vs. phenotype directed gene screening in CMT patients from Turkey

Sivaci M., Parman Y., Gonzaga-Jauregui C., Pehlivan D., Durmus H., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.21, ss.209, (Özet Bildiri)

60. Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation

Matur Z., Atmaca M. M., Durmus H., Parman Y.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

61. Clinical and genetic features of the patients with MNGIE: cohort at the department of neurology, Istanbul Faculty of Medicine

Cakar A., Durmus H., Gunduz T., Deymeer F., Parman Y., Oflazer-Serdaroglu P.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

62. The distinct genetic pattern of ALS in Turkey

Ozoguz A., Uyan O., Birdal G., Iskender C., Omur O., Lahut S., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

63. The distinct genetic pattern of ALS in Turkey

Ozoguz A., Uyan O., Birdal G., Iskender C., Omur O., Lahut S., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.21, ss.63, (Özet Bildiri)

64. Genotype-Phenotype Evaluation In 476 Turkish Dystrophinopathy Patients

Durmuş H., GEYİK F., ERGINEL-UENALTUNA N., PODA M., Çakar A., Altınkaya A., et al.

The 66th AAN Annual Meeting, Philadelphia, Amerika Birleşik Devletleri, 26 Nisan 2014 - 03 Mayıs 0215, ss.96, (Tam Metin Bildiri)

65. Distribution and Severity of Weakness in Patients with Polymyositis and Dermatomyositis: Different Pathophysiology, Different Affected Muscle Groups

Durmus H., Deymeer F., Parman Y., Serdaroglu P.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80, (Özet Bildiri)

66. Clinical and Genetic Characteristics of Five Turkish Families with UBQLN2 Mutations

Durmus H., Ozoguz A., Deymeer F., Serdaroglu P., Aysal F., Ertas M., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80, (Özet Bildiri)

67. IN-HOSPITAL STROKE RECURRENCE OF ACUTE ISCEMIC STROKE

Durmuş Tekçe H., Yeşilot N., Tuncay R., Çoban O., Zarkobahar S.

21.European Stroke Conference, Lisbon, Portekiz, 22 - 24 Mayıs 2012, ss.651-652, (Özet Bildiri)

68. Using whole exome sequencing to identify the mutation causing oculopharyngodistal myopathy

Wagner M., Laval S., Mueller J., Durmus H., Serdaroglu-Oflazer P., Lochmueller H.

United Kingdom Neuromuscular Translational Research Conference, Newcastle-Upon-Tyne, Birleşik Krallık, 22 - 23 Mart 2012, cilt.22, (Özet Bildiri)

69. Clinical Features of the "Optineurin" Mutation in familial FTD and ALS

Cikrikcili U., Durmus H., Basak N., Gunel M., GÜRVİT İ. H., Matur Z., et al.

8th International Conference on Frontotemporal Dementias, Manchester, Birleşik Krallık, 5 - 07 Eylül 2012, cilt.33, ss.231, (Özet Bildiri)

70. Oculopharyngodistal Myopathy Is a Distinct Entity - Clinical and Genetic Characterization of 40 Turkish OPDM Patients

Durmus H., Laval S. H., Deymeer F., Parman Y., Kiyan E., Gokyigit M., et al.

62nd Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 10 - 17 Nisan 2010, (Özet Bildiri)

71. Anti-neuronal antibodies in Hashimoto's thyroiditis patients with central nervous system involvement

Durmuş H., Icoez S., Tuezuen E., Kuertuencue M., Hanagasi H. A., Bebek N., et al.

18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, ss.139, (Özet Bildiri)

72. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis: is it auto-immune?

KURTUNCU M., TUZUN E., ICOZ S., Baslo B., KAYA D., DURMUS H., et al.

18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, cilt.255, ss.216-217, (Özet Bildiri)

73. Demographic and clinical statistics of multiple sclerosis and demyelinating diseases in an outpatients clinic, Istanbul Faculty of Medicine

Kurtuncu M., Peldivan M., Durmus H., Mutlu M., Yesilot N., Korkmaz F., et al.

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Çek Cumhuriyeti, 11 - 14 Ekim 2007

74. Epileptic seizures in multiple sclerosis

Durmus H., Kurtuncu M., Matur Z., Pehlivan M., Mutlu M., Yapici Z., et al.

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Çek Cumhuriyeti, 11 - 14 Ekim 2007, cilt.13

75. The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up

Eraksoy M., Akinan-Demir G., Yapici Z., Kurtuncu M., Mutlu M., Topcular B., et al.

17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, ss.39, (Özet Bildiri)

76. Devic's neuromyelitis optica: a prospective study

Eraksoy M., Akman-Demir G., Kurtuncu M., Yapici Z., Mutlu M., Topcular B., et al.

17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, ss.36

Kitaplar 3

1. Familial Amiloid Polinöropati - Dünya ve Türkiye Deneyimi Yeni Gelişmeler Işığında Transtiretin İlişkili Ailevi Amiloid Polinöropatisi

ÇAKAR A., DURMUŞ TEKÇE H., DEYMEER F., OFLAZER P., PARMAN F. Y.

Nadir Hastalıklar Pompe, Fabry ve TTR-FAP, Hilmi Uysal, Editör, Palme Yayınevi, Ankara, ss.177-190, 2020

2. Konjenital Miyopatiler

DURMUŞ TEKÇE H.

ÇOCUK VE ERGENDE NÖROLOJİK HASTALIKLARA YAKLAŞIMREHBER KİTABI, Ayşın DerventSemih AytaÖzlem ÇokarDerya Uludüz, Editör, Türk Nöroloji Derneği, ss.259-262, 2015

3. Juvenil Myastenia Gravis

DURMUŞ TEKÇE H., DEYMEER F.

ÇOCUK VE ERGENDE NÖROLOJİK HASTALIKLARAYAKLAŞIM REHBER KİTABI, Ayşın DerventSemih AytaÖzlem ÇokarDerya Uludüz, Editör, Türk Nöroloji Derneği, ss.320-324, 2015

Metrikler

Yayın

179

Yayın (WoS)

158

Yayın (Scopus)

Atıf (WoS)

1447

H-İndeks (WoS)

Atıf (Scopus)

1649

H-İndeks (Scopus)

Atıf (Scholar)

257

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler